10-Q: Clorox Q1 Earnings Plunge Amid ERP Transition, Macro Headwinds

Clorox reports a significant 19% drop in net sales and diluted EPS for Q1 FY26, primarily due to ERP system transition impacts and ongoing macroeconomic pressures.

Summary

• Net sales decreased by 19% to $1,429 million for the three months ended September 30, 2025, compared to $1,762 million in the prior year.
• Diluted net earnings per share (EPS) fell by 19% to $0.65, down from $0.80 in the same period last year.
• Gross profit declined by 26% to $596 million, with gross margin decreasing by 410 basis points to 41.7%.
• The decline in sales and volume was primarily attributed to lower shipments following incremental shipments related to the ERP transition in the previous fiscal quarter.
• All reportable segments experienced net sales decreases: Health and Wellness (-19%), Household (-19%), Lifestyle (-23%), and International (-2%).
• Net cash provided by operations decreased to $93 million from $221 million in the prior year, mainly due to lower cash earnings.
• The Glad venture agreement with Procter & Gamble will terminate in January 2026, requiring Clorox to purchase P&G's 20% interest for an estimated fair value of $476 million.
• Operating expenses related to digital capabilities and productivity enhancements investment were $32 million, part of an expected total incremental transformational investment of approximately $580 million.
• The effective tax rate on earnings was 23.4%, significantly lower than 41.8% in the prior period, primarily due to the non-deductibility of a divestiture loss in the prior year.

Sentiment

Score: 3

Explanation: The overall sentiment is negative due to significant declines across key financial metrics (sales, gross profit, EPS) and cash flow. While some issues are attributed to a temporary ERP transition, the magnitude of the decline and ongoing macroeconomic/geopolitical headwinds suggest a challenging period. The upcoming Glad venture obligation also adds a notable liability.

Positives

• The effective tax rate decreased to 23.4% from 41.8% in the prior period, mainly due to the non-deductibility of a divestiture loss in the prior year.
• Segment adjusted EBIT for Corporate and Other increased by 25%, driven by reductions in employee-related expenses and lower operating expenses from the divested Better Health VMS business.
• The company's financial condition and liquidity remained strong as of September 30, 2025, with access to capital markets and a $1,200 million revolving credit agreement with no outstanding borrowings.
• The company continues to invest in its brands, capabilities, and people, with U.S. retail advertising investments as a percentage of net sales increasing from 12% to 13%.

Negatives

• Net sales decreased by 19% and diluted EPS by 19% year-over-year, indicating a significant decline in performance.
• Gross profit decreased by 26%, and gross margin declined by 410 basis points, primarily due to lower volume and higher manufacturing and logistics costs.
• All major segments (Health and Wellness, Household, Lifestyle, International) reported declines in net sales and segment adjusted EBIT.
• Net cash provided by operations significantly decreased to $93 million from $221 million in the prior period, mainly due to lower cash earnings.
• Current liabilities exceeded current assets by $539 million as of September 30, 2025, largely due to the upcoming Glad venture terminal obligation.
• The company is in the stabilization phase of its ERP transition and has experienced sales timing impacts, contributing to lower shipments.

Risks

• Unfavorable general economic and geopolitical conditions, including inflation, supply chain disruptions, labor shortages, wage pressures, fuel and energy costs, interest rate fluctuations, and foreign currency exchange rate fluctuations.
• Impact of market and category declines, and product and geographic mix on the ability to meet sales growth targets.
• Ability to successfully execute or realize anticipated benefits of strategic or transformational initiatives, including the ERP transition and related shipment timing.
• Volatility and increases in the costs of raw materials, energy, transportation, labor, and other necessary supplies or services.
• Risks related to supply chain issues, product shortages, and disruptions due to an expanded supplier network and reliance on single-source suppliers.
• Risks related to the company's use of and reliance on information technology systems, including potential and actual security breaches, cyberattacks, and data breaches.
• Ability to successfully manage global political, legal, tax, and regulatory risks, including regulatory uncertainty and lack of convergence among different jurisdictions.
• Dependence on key customers and risks related to customer consolidation and ordering patterns.
• Risks related to the acquisition of P&G's interest in the Glad business, including potential changes in fair value estimates.
• Environmental matters, including costs associated with remediation and monitoring of past contamination, and potential increases in costs from regulatory actions.

Future Outlook

The company anticipates that the operating environment will remain volatile and challenging, with consumers potentially facing greater pressure due to continued macroeconomic uncertainty impacting spending. Clorox plans to continue investing in its brands, capabilities, and people to deliver consistent, profitable growth over time. The ERP implementation is on track to be completed this fiscal year, and the Glad venture terminal obligation is expected to be repaid through anticipated positive cash flows, access to capital markets, and current borrowing availability.

Management Comments

• "The Company continues to monitor macroeconomic conditions as a result of volatility in capital markets and developments in international trade policy."
• "While inflationary headwinds have moderated, consumers continue to feel pressure as continued macroeconomic uncertainty impacts spending and prices remain elevated."
• "The Company anticipates that the operating environment will remain volatile and challenging."
• "The Company has not experienced significant disruptions in its operations during the first quarter of fiscal year 2026. However, the risks of future negative impacts due to transportation, logistical or supply constraints and higher commodity costs for certain raw materials remain present."
• "The Company remains on track to complete implementation [of the ERP system] this fiscal year."
• "For the remainder of fiscal year 2026, the Company anticipates that the operating environment will remain volatile and challenging as consumers may face greater pressure as continued macroeconomic uncertainty impacts spending."
• "The Company will continue to invest in its brands, capabilities and people to deliver consistent, profitable growth over time."
• "The Company believes it will have the funds necessary to support its shortand long-term liquidity and operating needs, including its digital capabilities and productivity enhancements investment and venture agreement terminal obligation."

Industry Context

The consumer staples industry, particularly household and personal care products, is currently navigating a complex environment characterized by moderating but persistent inflation, cautious consumer spending, and evolving trade policies. Companies like Clorox are facing pressure from elevated prices for raw materials and logistics, while also investing in digital transformation to enhance efficiency and growth. Geopolitical instability adds another layer of uncertainty, potentially impacting supply chains and global demand. The sector generally sees stable demand, but current conditions are testing profitability and requiring strategic adjustments.

Comparison to Industry Standards

• NA

Corporate Governance

Legal Proceedings

• The company is involved in certain environmental matters, including response actions at various locations, with recorded liabilities totaling $27 million as of September 30, 2025.
• One matter in Alameda County, California, has a recorded liability of $12 million, with potential additional undiscounted costs up to approximately $28 million over an estimated 30-year period.
• Another matter in Dickinson County, Michigan, has a recorded liability of $10 million, where the company is jointly and severally liable for 24.3% of costs, with a possibility of greater exposure if the third party is unable to pay its share.
• From time to time, the company is subject to various legal proceedings, claims, and other loss contingencies, which management believes will not have a material adverse effect on the consolidated financial statements.

Related Party Transactions

• The company has an agreement with The Procter & Gamble Company (P&G) for its Glad bags and wraps business, in which P&G holds a 20% interest. The agreement terminates in January 2026, requiring Clorox to purchase P&G's interest for cash at fair value (estimated $476 million).

Stakeholder Impact

• Shareholders: Experienced a 19% decrease in diluted EPS and a decline in stock repurchase activity compared to the prior period, though dividends per share declared increased slightly.
• Employees: The company is undergoing a technology transformation (ERP implementation) which impacts internal processes and controls. Employee incentive compensation was lower.
• Customers: Experienced lower shipments due to ERP transition impacts, which could affect product availability or order fulfillment timing.
• Suppliers: The company offers a voluntary supply chain finance program, allowing suppliers to receive early payments from a financial institution, which can benefit participating suppliers' liquidity.
• Creditors: The company maintains strong credit ratings and access to capital markets, indicating continued ability to meet debt obligations, despite current liabilities exceeding current assets due to the Glad venture obligation.

Next Steps

• Complete the phased implementation of the new enterprise resource planning system (ERP) this fiscal year.
• Purchase P&G's 20% interest in the Glad bags and wraps business for cash at fair value upon the agreement's termination in January 2026.
• Continue to monitor macroeconomic conditions, international trade policies, and geopolitical instability.
• Continue to invest in brands, capabilities, and people to drive consistent, profitable growth.
• Manage potential future negative impacts from transportation, logistical or supply constraints, and higher commodity costs.

Key Dates

Recommendation

The significant declines in net sales, gross profit, and EPS are concerning, reflecting a challenging operating environment and the impact of the ERP transition. While the ERP transition is a temporary factor, the magnitude of the financial deterioration suggests underlying pressures. The company's strong brand portfolio and ongoing investments in digital transformation offer long-term potential. However, the immediate financial performance and the upcoming Glad venture obligation warrant a cautious stance. A 'hold' recommendation allows investors to monitor the successful completion of the ERP implementation and the company's ability to navigate macroeconomic headwinds and restore growth and margins before making further investment decisions.

Keywords

Clorox, 10-Q, Quarterly Report, Consumer Products, Household Goods, Financial Results, Net Sales, EPS, Gross Margin, ERP System, Macroeconomic Conditions, Supply Chain, Divestiture, Glad Venture, Risk Factors